Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Therapeutic Advances in Pituitary Carcinoma. | J Immunother Precis Oncol | 2023 | 37214211 | PubTator, text mining | PubMed |
| Meningothelial hamartoma on the forehead of a young cat. | J Comp Pathol | 2023 | 37207418 | PubTator, text mining | PubMed |
| Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors. | Front Endocrinol (Lausanne) | 2023 | 37206441 | PubTator, text mining | PubMed |
| SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022). | Clin Transl Oncol | 2023 | 37204633 | PubTator, text mining | PubMed |
| Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression. | EJNMMI Res | 2023 | 37204528 | PubTator, text mining | PubMed |
| Current status of contemporary diagnostic radiotracers in the management of breast cancer: first steps toward theranostic applications. | EJNMMI Res | 2023 | 37195374 | PubTator, text mining | PubMed |
| Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R. | Cancers (Basel) | 2023 | 37190273 | PubTator, text mining | PubMed |
| Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. | Cancers (Basel) | 2023 | 37190261 | PubTator, text mining | PubMed |
| Neuroendocrine Tumors: Genomics and Molecular Biomarkers with a Focus on Metastatic Disease. | Cancers (Basel) | 2023 | 37190177 | PubTator, text mining | PubMed |
| The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy. | Cancers (Basel) | 2023 | 37190151 | PubTator, text mining | PubMed |
| Multi-Omics and Management of Follicular Carcinoma of the Thyroid. | Biomedicines | 2023 | 37189835 | PubTator, text mining | PubMed |
| Double Pituitary Adenomas in Patients With Cushing's Disease. | Cureus | 2023 | 37188065 | PubTator, text mining | PubMed |
| Hot Embolus Artifact Mimicking Disease Progression in Post-therapy 177Lu-DOTATATE Scan: Incremental Value of SPECT/CT. | Nucl Med Mol Imaging | 2023 | 37187952 | PubTator, text mining | PubMed |
| Treatment Response of Sacrococcygeal Chordoma to Palliative Stereotactic Body Radiotherapy: A Case Report. | Case Rep Oncol | 2023 | 37187687 | PubTator, text mining | PubMed |
| A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience. | Curr Oncol | 2023 | 37185426 | PubTator, text mining | PubMed |
| Vaccinia virus and peptide-receptor radiotherapy synergize to improve treatment of peritoneal carcinomatosis. | Mol Ther Oncolytics | 2023 | 37180034 | PubTator, text mining | PubMed |
| Imaging manifestations of phosphaturic mesenchymal tumors: a description of two cases. | Quant Imaging Med Surg | 2023 | 37179952 | PubTator, text mining | PubMed |
| Occurrence of parathyroid carcinoma following parathyroid adenoma resection. | Quant Imaging Med Surg | 2023 | 37179950 | PubTator, text mining | PubMed |
| CT features of primary pleural gritty meningioma: A case report and review of the literature. | Acta Radiol Open | 2023 | 37179795 | PubTator, text mining | PubMed |
| A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinism. | J Biol Chem | 2023 | 37178920 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=30